|
|||||||
 |
 |
|
|||||
|
 |
|
|||||
|
|||||||
|
 |
|
|||||
|
|||||||
|
 |
|
|||||
|
|||||||
|
 |
|
|||||
|
|||||||
|
 |
|
|||||
|
|||||||
|
 |
|
|||||
|
|||||||
|
|
|
|
|
|
|
|
Info artsen
BELGISCHE VERENIGING IVM HUIDKANKER
ASSOCIATION BELGE CONCERNANT CANCER DE PEAU
- Treatment recommendations
- Program BADO meeting 16/01/16
- Hand-outs BADO meeting 16/01/16
- Photo-immunology and the skin
Thomas Schwarz, Kiel - Skin cancer in transplant patients
Günther Hofbauer, Zürich - Skin cancers in patients treated with immunomodulating drugs/Manuel Viguier, Paris
- Topical immunotherapy and skin cancer: indications
Marjan Garmyn, UZ Leuven - Specific side effects of the new immunotherapies: case illustrations
Pascal Wolter, UZ Leuven - Systemic immunotherapy in melanoma: where are we ?Pol Specenier, UZ Antwerpen
- Photo-immunology and the skin
- Hand-outs BADO meeting 16/01/16
home - melanoom - info artsen
|
|||||||
|
|
|
|||||
|
|
|
|||||
|
|||||||
|
 |
|
|||||
|
|||||||
|
|
|
|||||
|
|||||||
|
 |
|
|||||
|
|||||||
|
|||||||
|
|
|
|||||
|
 |
|
|||||
|
|||||||
|
|||||||
 |
|
||||||
|
|||||||
|
|
|
|
|
|
|
|
BELGISCHE VERENIGING IVM HUIDKANKER
ASSOCIATION BELGE CONCERNANT CANCER DE PEAU
Program BADO meeting 24/01/17
(Targeted therapies and their cutaneous toxities)
Program
Consensus EGFR inhibitors-skintoxicity
1.EGFR INHIBITORS Use in oncology
2.EGFR INHIBITORS Skin toxicity
3.MULTIKINASE INHIBITORS Use in oncology
4.MULTIKINASE INHIBITORS Skin toxicity
5.BRAF INHIBITORS Use in oncology
6.BRAF INHIBITORS Skin toxicity
Info artsen
Copyright 2013-2019 * BADO * Webdesign ASFE